Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on December 22, 2004
J Am Soc Nephrol 16: 520-528, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2004070602
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2004070602v1
16/2/520    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kestenbaum, B.
Right arrow Articles by Andress, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kestenbaum, B.
Right arrow Articles by Andress, D. L.

Epidemiology and Outcomes

Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease

Bryan Kestenbaum*, Joshua N. Sampson{dagger}, Kyle D. Rudser{dagger}, Donald J. Patterson{ddagger}, Stephen L. Seliger§, Bessie Young||,¶, Donald J. Sherrard* and Dennis L. Andress*

* Division of Nephrology, University of Washington, Veterans’ Affairs Puget Sound Health Care System; Departments of; {dagger} Biostatistics and {ddagger} Computer Science and Engineering, and § Division of Nephrology, University of Washington; || Division of General Internal Medicine, University of Washington, Veterans’ Affairs Puget Sound Health Care System; and Northwest Kidney Centers, Seattle, Washington

Address correspondence to: Dr. Bryan Kestenbaum, Veterans’ Affairs Puget Sound Health Care System, Division of Nephrology, Mail Stop 111A, 1660 South Columbian Way, Seattle, WA 98108. Phone: 206-277-3192; Fax: 206-764-2022; brk{at}u.washington.edu

Elevated serum phosphate levels have been linked with vascular calcification and mortality among dialysis patients. The relationship between phosphate and mortality has not been explored among patients with chronic kidney disease (CKD). A retrospective cohort study was conducted from eight Veterans Affairs’ Medical Centers located in the Pacific Northwest. CKD was defined by two continuously abnormal outpatient serum creatinine measurements at least 6 mo apart between 1999 and 2002. Patients who received chronic dialysis, those with a present or previous renal transplant, and those without a recent phosphate measurement were excluded. The primary end point was all-cause mortality. Secondary end points were acute myocardial infarction and the combined end point of myocardial infarction plus death. A total of 95,619 veterans with at least one primary care or internal medicine clinic contact from a Northwest VA facility and two or more outpatient measurements of serum creatinine, at least 6 mo apart, between January 1, 1999, and December 31, 2002, were identified. From this eligible population, 7021 patients met our definition of CKD. After exclusions, 6730 CKD patients were available for analysis, and 3490 had a serum phosphate measurement during the previous 18 mo. After adjustment, serum phosphate levels >3.5 mg/dl were associated with a significantly increased risk for death. Mortality risk increased linearly with each subsequent 0.5-mg/dl increase in serum phosphate levels. Elevated serum phosphate levels were independently associated with increased mortality risk among this population of patients with CKD.




This article has been cited by other articles:


Home page
 NEJMHome page
H. Abboud and W. L. Henrich
Stage IV Chronic Kidney Disease
N. Engl. J. Med., January 7, 2010; 362(1): 56 - 65.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
D. H. Smith, E. S. Johnson, M. L. Thorp, A. Petrik, X. Yang, and D. K. Blough
Outcomes predicted by phosphorous in chronic kidney disease: a retrospective CKD-inception cohort study
Nephrol. Dial. Transplant., January 1, 2010; 25(1): 166 - 174.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
C. B. Langman and J. B. Cannata-Andia
Calcium in Chronic Kidney Disease: Myths and Realities
Clin. J. Am. Soc. Nephrol., January 1, 2010; 5(Supplement_1): S1 - S2.
[Full Text] [PDF]

Home page
 CJASNHome page
M. Peacock
Calcium Metabolism in Health and Disease
Clin. J. Am. Soc. Nephrol., January 1, 2010; 5(Supplement_1): S23 - S30.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
P. Raggi, S. Vukicevic, R. M. Moyses, K. Wesseling, and D. M. Spiegel
Ten-Year Experience with Sevelamer and Calcium Salts as Phosphate Binders
Clin. J. Am. Soc. Nephrol., January 1, 2010; 5(Supplement_1): S31 - S40.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
S. L. West, V. J. D. Swan, and S. A. Jamal
Effects of Calcium on Cardiovascular Events in Patients with Kidney Disease and in a Healthy Population
Clin. J. Am. Soc. Nephrol., January 1, 2010; 5(Supplement_1): S41 - S47.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
S. Nakamura, H. Ishibashi-Ueda, S. Niizuma, F. Yoshihara, T. Horio, and Y. Kawano
Coronary Calcification in Patients with Chronic Kidney Disease and Coronary Artery Disease
Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(12): 1892 - 1900.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
E. Ritz, H Krum, M Schlaich, R Whitbourn, P. Sobotka, J Sadowski, K Bartus, B Kapelak, A Walton, H Sievert, et al.
New Approaches to Pathogenesis and Management of Hypertension
Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(12): 1886 - 1891.
[Full Text] [PDF]

Home page
 CJASNHome page
E. Ritz and J. Bommer
Cardiovascular Problems on Hemodialysis: Current Deficits and Potential Improvement
Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(Supplement_1): S71 - S78.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Tonelli, G. Curhan, M. Pfeffer, F. Sacks, R. Thadhani, M. L. Melamed, N. Wiebe, and P. Muntner
Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality
Circulation, November 3, 2009; 120(18): 1784 - 1792.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
J. F. Navarro-Gonzalez, C. Mora-Fernandez, M. Muros, H. Herrera, and J. Garcia
Mineral Metabolism and Inflammation in Chronic Kidney Disease Patients: A Cross-Sectional Study
Clin. J. Am. Soc. Nephrol., October 1, 2009; 4(10): 1646 - 1654.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
G. J. Becker, R. G. Walker, T. D. Hewitson, and E. Pedagogos
Phosphate levels--time for a rethink?
Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2321 - 2324.
[Full Text] [PDF]

Home page
 CJASNHome page
J. Uribarri
Phosphorus Additives in Food and their Effect in Dialysis Patients
Clin. J. Am. Soc. Nephrol., August 1, 2009; 4(8): 1290 - 1292.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Cirillo, G. Botta, D. Chiricone, and N. G. De Santo
Glomerular filtration rate and serum phosphate: an inverse relationship diluted by age
Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2123 - 2131.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
E. Neven, G. Dams, A. Postnov, B. Chen, N. De Clerck, M. E. De Broe, P. C. D'Haese, and V. Persy
Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats
Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1790 - 1799.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
Y.-W. Chiu, I. Teitelbaum, M. Misra, E. M. de Leon, T. Adzize, and R. Mehrotra
Pill Burden, Adherence, Hyperphosphatemia, and Quality of Life in Maintenance Dialysis Patients
Clin. J. Am. Soc. Nephrol., June 1, 2009; 4(6): 1089 - 1096.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. Anderson, J. B. Halter, W. R. Hazzard, J. Himmelfarb, F. M. Horne, G. A. Kaysen, J. W. Kusek, S. G. Nayfield, K. Schmader, Y. Tian, et al.
Prediction, Progression, and Outcomes of Chronic Kidney Disease in Older Adults
J. Am. Soc. Nephrol., June 1, 2009; 20(6): 1199 - 1209.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
O. M. Gutierrez, J. L. Januzzi, T. Isakova, K. Laliberte, K. Smith, G. Collerone, A. Sarwar, U. Hoffmann, E. Coglianese, R. Christenson, et al.
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Circulation, May 19, 2009; 119(19): 2545 - 2552.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Covic, P. Kothawala, M. Bernal, S. Robbins, A. Chalian, and D. Goldsmith
Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease
Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1506 - 1523.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
S. C. Palmer, J. C. Craig, and G. F. M. Strippoli
Taking aim at targets
Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1358 - 1361.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
F. Tentori, J. M. Albert, E. W. Young, M. J. Blayney, B. M. Robinson, R. L. Pisoni, T. Akiba, R. N. Greenwood, N. Kimata, N. W. Levin, et al.
The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study
Nephrol. Dial. Transplant., March 1, 2009; 24(3): 963 - 972.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
C. Sullivan, S. S. Sayre, J. B. Leon, R. Machekano, T. E. Love, D. Porter, M. Marbury, and A. R. Sehgal
Effect of Food Additives on Hyperphosphatemia Among Patients With End-stage Renal Disease: A Randomized Controlled Trial
JAMA, February 11, 2009; 301(6): 629 - 635.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
K. L. Adeney, D. S. Siscovick, J. H. Ix, S. L. Seliger, M. G. Shlipak, N. S. Jenny, and B. R. Kestenbaum
Association of Serum Phosphate with Vascular and Valvular Calcification in Moderate CKD
J. Am. Soc. Nephrol., February 1, 2009; 20(2): 381 - 387.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. Isakova, O. M. Gutierrez, Y. Chang, A. Shah, H. Tamez, K. Smith, R. Thadhani, and M. Wolf
Phosphorus Binders and Survival on Hemodialysis
J. Am. Soc. Nephrol., February 1, 2009; 20(2): 388 - 396.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
S. J. Onufrak, A. Bellasi, F. Cardarelli, V. Vaccarino, P. Muntner, L. J. Shaw, and P. Raggi
Investigation of Gender Heterogeneity in the Associations of Serum Phosphorus With Incident Coronary Artery Disease and All-Cause Mortality
Am. J. Epidemiol., January 1, 2009; 169(1): 67 - 77.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
S. M. Sprague, H. Abboud, P. Qiu, M. Dauphin, P. Zhang, and W. Finn
Lanthanum Carbonate Reduces Phosphorus Burden in Patients with CKD Stages 3 and 4: A Randomized Trial
Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 178 - 185.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
C. S Shinaberger, S. Greenland, J. D Kopple, D. Van Wyck, R. Mehrotra, C. P Kovesdy, and K. Kalantar-Zadeh
Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?
Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1511 - 1518.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
A. Levin MD, B. Hemmelgarn MD PhD, B. Culleton MD MSc, S. Tobe MD, P. McFarlane MD PhD, M. Ruzicka MD PhD, K. Burns MD, B. Manns MD MSc, C. White MD, F. Madore MD MSc, et al.
Guidelines for the management of chronic kidney disease
Can. Med. Assoc. J., November 18, 2008; 179(11): 1154 - 1162.
[Full Text] [PDF]

Home page
 CJASNHome page
P. A. McCullough, V. Agrawal, E. Danielewicz, and G. S. Abela
Accelerated Atherosclerotic Calcification and Monckeberg's Sclerosis: A Continuum of Advanced Vascular Pathology in Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1585 - 1598.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
O. M. Gutierrez, M. Mannstadt, T. Isakova, J. A. Rauh-Hain, H. Tamez, A. Shah, K. Smith, H. Lee, R. Thadhani, H. Juppner, et al.
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
N. Engl. J. Med., August 7, 2008; 359(6): 584 - 592.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
M. Ketteler, M. Rix, S. Fan, N. Pritchard, O. Oestergaard, S. Chasan-Taber, J. Heaton, A. Duggal, and P. A. Kalra
Efficacy and Tolerability of Sevelamer Carbonate in Hyperphosphatemic Patients Who Have Chronic Kidney Disease and Are Not on Dialysis
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1125 - 1130.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. Mathew, K. S. Tustison, T. Sugatani, L. R. Chaudhary, L. Rifas, and K. A. Hruska
The Mechanism of Phosphorus as a Cardiovascular Risk Factor in CKD
J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1092 - 1105.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
C. P. Kovesdy, S. Ahmadzadeh, J. E. Anderson, and K. Kalantar-Zadeh
Association of Activated Vitamin D Treatment and Mortality in Chronic Kidney Disease
Arch Intern Med, February 25, 2008; 168(4): 397 - 403.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
B. Cianciaruso, A. Pota, A. Pisani, S. Torraca, R. Annecchini, P. Lombardi, A. Capuano, P. Nazzaro, V. Bellizzi, and M. Sabbatini
Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial
Nephrol. Dial. Transplant., February 1, 2008; 23(2): 636 - 644.
[Abstract] [Full Text] [PDF]

Home page
 NDT PlusHome page
M. Chonchol and R. P. Wuthrich
Potential Future Uses of Calcimimetics in Patients with Chronic Kidney Disease
NDT Plus, January 1, 2008; 1(suppl_1): i36 - i41.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
D. Muller, H. Mehling, B. Otto, R. Bergmann-Lips, F. Luft, J. Jordan, and R. Kettritz
Niacin Lowers Serum Phosphate and Increases HDL Cholesterol in Dialysis Patients
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1249 - 1254.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
N. Voormolen, M. Noordzij, D. C. Grootendorst, I. Beetz, Y. W. Sijpkens, J. G. van Manen, E. W. Boeschoten, R. M. Huisman, R. T. Krediet, F. W. Dekker, et al.
High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients
Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2909 - 2916.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
D. Fliser, B. Kollerits, U. Neyer, D. P. Ankerst, K. Lhotta, A. Lingenhel, E. Ritz, F. Kronenberg, and for the MMKD Study Group
Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study
J. Am. Soc. Nephrol., September 1, 2007; 18(9): 2600 - 2608.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. M. Brunelli and S. Goldfarb
Hypophosphatemia: Clinical Consequences and Management
J. Am. Soc. Nephrol., July 1, 2007; 18(7): 1999 - 2003.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
R. Dhingra, L. M. Sullivan, C. S. Fox, T. J. Wang, R. B. D'Agostino Sr, J. M. Gaziano, and R. S. Vasan
Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the Community
Arch Intern Med, May 14, 2007; 167(9): 879 - 885.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R. Villa-Bellosta, Y. E. Bogaert, M. Levi, and V. Sorribas
Characterization of Phosphate Transport in Rat Vascular Smooth Muscle Cells: Implications for Vascular Calcification
Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 1030 - 1036.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
L. Craver, M. P. Marco, I. Martinez, M. Rue, M. Borras, M. L. Martin, F. Sarro, J. M. Valdivielso, and E. Fernandez
Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges
Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1171 - 1176.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
W. Lee, S. Campoy, G. Smits, Z. Vu Tran, and M. Chonchol
Effectiveness of a chronic kidney disease clinic in achieving K/DOQI guideline targets at initiation of dialysis--a single-centre experience
Nephrol. Dial. Transplant., March 1, 2007; 22(3): 833 - 838.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
F. Koiwa, T. Kakuta, R. Tanaka, and S. Yumita
Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism
Nephrol. Dial. Transplant., February 1, 2007; 22(2): 522 - 528.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. Jofre, P. Rodriguez-Benitez, J. M. Lopez-Gomez, and R. Perez-Garcia
Inflammatory Syndrome in Patients on Hemodialysis
J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S274 - S280.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
K. C. Norris, T. Greene, J. Kopple, J. Lea, J. Lewis, M. Lipkowitz, P. Miller, A. Richardson, S. Rostand, X. Wang, et al.
Baseline Predictors of Renal Disease Progression in the African American Study of Hypertension and Kidney Disease
J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2928 - 2936.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
C. Tomiyama, A. Higa, M. A. Dalboni, M. Cendoroglo, S. A. Draibe, L. Cuppari, A. B. Carvalho, E. M. Neto, and M. E. F. Canziani
The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients
Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2464 - 2471.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. Tonelli, F. Sacks, M. Pfeffer, Z.H. Gao, G. Curhan, for the Cholesterol and Recurrent Events (CARE) Tr, P. Rossing, K. Rossing, P. Gaede, O. Pedersen, et al.
Serum Phosphate: A Novel Cardiovascular Risk Factor Even in Nonrenal Patients: Relation between Serum Phosphate Level and Cardiovascular Event Rate in People with Coronary Disease. Circulation 112: 2627-2633, 2005
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2077 - 2085.
[Full Text] [PDF]

Home page
 CJASNHome page
D. A. Bushinsky
Phosphate Binders: Hold the Calcium?
Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 695 - 696.
[Full Text] [PDF]

Home page
 CJASNHome page
S. Schwarz, B. K. Trivedi, K. Kalantar-Zadeh, and C. P. Kovesdy
Association of Disorders in Mineral Metabolism with Progression of Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 825 - 831.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Arici, S. Kahraman, G. Genctoy, B. Altun, U. Kalyoncu, A. Oto, S. Kirazli, Y. Erdem, U. Yasavul, and C. Turgan
Association of mineral metabolism with an increase in cellular adhesion molecules: another link to cardiovascular risk in maintenance haemodialysis?
Nephrol. Dial. Transplant., April 1, 2006; 21(4): 999 - 1005.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
H. Reichel
Current treatment options in secondary renal hyperparathyroidism
Nephrol. Dial. Transplant., January 1, 2006; 21(1): 23 - 28.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. Shlipak and C. Stehman-Breen
Observational Research Databases in Renal Disease
J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3477 - 3484.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Tonelli, F. Sacks, M. Pfeffer, Z. Gao, G. Curhan, and for the Cholesterol And Recurrent Events (CARE) Tr
Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease
Circulation, October 25, 2005; 112(17): 2627 - 2633.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
G. M. Chertow and S. M. Moe
Calcification or Classification?
J. Am. Soc. Nephrol., February 1, 2005; 16(2): 293 - 295.
[Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673